July 28, 2010
Kyowa Hakko Kirin First Half Sales and Profits Up:
Full-year Sales and Operating Profit Forecast Raised(50KB)

July 28, 2010
Kyowa Hakko Kirin
Fiscal 2010 Interim Results(1186KB)

July 28, 2010
Appendix to the Fiscal 2010 Interim Consolidated Financial Statements(113KB)

July 28, 2010
Consolidated Financial Summary
Fiscal 2010 Interim (January 1, 2010 - June 30, 2010)(116KB)

June 3, 2010
Kyowa Hakko Kirin to enter out-licensing agreement with Biovail for
anti-Parkinson's disease drug KW-6002 (Istradefylline) in North America

May 25, 2010
Kyowa Hakko Bio announced the reorganization of Yamaguchi Production Center

April 30, 2010
Appendix to the Fiscal 2010 First Quarter Consolidated Financial Statements(88KB)

April 28, 2010
Consolidated Financial Summary:
First Quarter of the Fiscal Year to December 2010(136KB)

April 28, 2010
Kyowa Hakko Kirin Announces Q1 Growth in Sales and Profits(40KB)

January 29, 2010
Kyowa Hakko Kirin Group:
Medium-term Business Plan 2010-2012(62KB)

January 29, 2010
Kyowa Hakko Kirin Forecasts 16.4% increase in 2010 Operating Income;
2009 Results in line with Revised Forecasts(71KB)

January 22, 2010
Kyowa Hakko Kirin Revises Down Profit Forecasts(41KB)

January 8, 2010
Kyowa Hakko Kirin and Reata Pharmaceuticals entered into a licensing agreement on bardoxolone methyl in Japan and other selected Asian markets.

October 29, 2009
Kyowa Hakko Kirin Reports Interim Results in line with Revised Forecasts(68KB)

October 22, 2009
Kyowa Hakko Kirin: Upward Revision of Sales and Profit Forecasts(44KB)

July 29, 2009
Kyowa Hakko Kirin Announces Q1 Results and Revises Forecasts Upward(113KB)

April 28, 2009
Kyowa Hakko Kirin Fiscal 2008 Sales up 17.4%, Operating Income up 15.2%(48KB)

January 30, 2009
Kyowa Hakko Kirin Third Quarter Results; Revision of full year forecasts; Planned change of fiscal year end(42KB)

January 15, 2009
Kyowa Hakko Kirin announced development policy for the anti-Parkinson’s disease drug KW-6002 (Istradefylline)